| NWSF Leadership
The Northwest Sarcoma Foundation leadership team brings together a diverse group of professionals united by a shared commitment to advancing progress in the fight against sarcoma. Representing a broad range of expertise across medicine, research, industry, and advocacy, this team combines deep clinical knowledge with strategic leadership and community engagement. Together, they help guide our mission to expand awareness, strengthen patient and caregiver resources, and drive critical fundraising efforts that support innovative research and future breakthroughs. Their collective experience and dedication play a vital role in accelerating progress and improving outcomes for those affected by sarcoma.
| Our Team
| NWSF Board of Directors
Michael Lillie
Board President
Michael Lillie, acting President for the Northwest Sarcoma Foundation, comes with over a decade experience and wealth of knowledge as a rare disease oncology manager startups.
Nick Casillas
Commvault, Board VP
Sarcoma Survivor, Volunteer and Enterprise level Network Security & Storage Technology executive.
Bella May
Bella Counseling, Board Treasurer
Bella Consulting:I have worked with adults and adolescents in a variety of settings since 1998. My first experience was working with youth in a shelter for runaway teens. It was here that I discovered my passion and gift of working with adolescents and young adults. I then spent several years teaching in inner city Chicago. This experience was transformative and I witnessed how difficult learning can be when a child is depressed, lonely, distracted, angry or anxious.
Mike Bell, PA
Providence Orthopedics
Physician Assistant, Surgery - Orthopedic Spokane, Washington
Michael Wagner, MD
Dana-Farber Cancer Institute
Dr. Wagner received his MD degree from Harvard Medical School and completed residency at Mt. Sinai Hospital in New York and fellowship in medical oncology at the University of Texas MD Anderson Cancer Center. Prior to joining Dana-Farber Cancer Institute in 2023, he was a member of the faculty at the University of Washington and Fred Hutch Cancer Center, where he was also the Director of Sarcoma Clinical Research. His research interests include angiosarcoma and other vascular sarcomas, and immunotherapy and targeted agents for bone and soft tissue sarcomas
Jeremy Sharib, MD
Fred Hutch Cancer Center
Surgical Oncologist, Assistant Professor of Surgery in the Department of Surgery. Dr. Sharib's clinical interests include treatment of gastrointestinal cancers including advanced/metastatic colon, rectal and gastric cancers, mucinous appendices neoplasms, gastrointestinal stromal tumors (GIST), neuroendocrine tumors (NET), peritoneal mesothelioma, and sarcoma.​
| Northwest Sarcoma Foundation Partnerships & Financials
Northwest Sarcoma Foundation was founded in 1996 and became recognized as a 501(c)(3) organization by the U.S. Internal Revenue Service (IRS) in 1997.
The Northwest Sarcoma Foundation's corporate sponsors, private donors, partnerships and nonprofit affiliations are the key to our success. To become part of our sarcoma community, or learn more, please join us!
Nonprofits share IRS Form 990 as public knowledge to maintain their tax-exempt status and demonstrate transparency to donors, grant-makers, and the public. The form provides a comprehensive picture of the foundations activities, governance practices, and operational details.
The Northwest Sarcoma Foundation annual report is a public report detailing the foundation’s activities and impact throughout the preceding year. Our purpose is to provide donors, investors, or potential partners, with information about the nonprofits operations and financial performance for the fiscal year.
The best way to find yourself is
to lose yourself in the service of others.
- Mahatma Gandhi